Imaging B Cell Follicles to Investigate HIV/SIV Persistence. Elizabeth Connick, M.D. University of Arizona May 8, 2017

Size: px
Start display at page:

Download "Imaging B Cell Follicles to Investigate HIV/SIV Persistence. Elizabeth Connick, M.D. University of Arizona May 8, 2017"

Transcription

1 Imaging B Cell ollicles to Investigate HIV/SIV Persistence Elizabeth Connick, M.D. University of Arizona May 8, 2017

2 Most HIV Replication Occurs In Secondary Lymphoid Tissues Tenner-Racz K et al. Am J Pathol 1986;123:9; Pantaleo G et al. Nature 1993:362:355; Embretson J et al. Nature 1993:362:3359 Lymph Node Structure

3 HIV Replication is Concentrated in in CD4+ T Cells in B Cell ollicles (i.e., TH) (Tenner-Racz K et al. Am J Pathol 1986;123:9; Biberfeld P et al. Am J Pathol 1986:125:436123:9; Hufert T et al. AIDS 1997;11:849; Tenner-Racz K et al. J Exp Med 1998;187:949) H IV-1 producing cells/m m A CD4+ cell in has a 31-fold (range, 6- to 155-fold) greater likelihood of being HIV RNA+ as a CD4+ cell in E. p = Subject inside follicle outside follicle olkvord J, et al. ARHR 2005: 21:363.

4 HIV Replication is Concentrated within Germinal Centers of ollicles GC Kohler S, et al. J Immunol, 2016; 196:2711

5 Are GC TH More Permissive than Tonsil Cell Infection with GP Reporter Virus Other CD4+ T Cells? GC T H CXCR5+PD-1 low Non-GC T H E Kohler S, et al. J Immunol, 2016; 196:2711

6 GP Expression in Tonsil Subsets R5 Virus X4 Virus % GP+ Percentage of GP+ Cells E CXCR5+ PD -1 low *** ns non-gc T H *** GC T H Percentage of GP+ Cells E CXCR5+ PD -1 low *** ns non-gc T H *** GC T H MI of GP gm I of G P+ C ells *** *** *** gm I of G P+ C ells ** *** *** 0 E CXCR5+ PD -1 low non-gc T H GC T H 0 E CXCR5+ PD -1 low non-gc T H GC T H Kohler S, et al. J Immunol, 2016; 196:2711

7 GP Expression in Sorted Tonsil Cell Subsets Percentage of GP+ Cells E CXCR5+PD-1 lo w GC T H T282 T290 T294 T165 T169 T171 R5 GC TH are highly permissive, but alter their phenotype during productive infection. X4 Kohler S, et al. J Immunol, 2016; 196:2711

8 Why Are CTL Unable to Suppress HIV Replication in B Cell ollicles? Inadequate numbers of CTL Escape from immune recognition Impaired effector mechanisms Immune privileged site

9 CD8+ T Cells and Many Antiviral Proteins Are Less Abundant in B-cell ollicles Protein HIV-1 seropositive subjects (N=15) Median Cells/mm 2 (range) E Median Cells/mm 2 (range) p value IN-α 0.4 ( ) 2.7 ( ) α-defensins 1, 2, ( ) 4.9 ( ) RANTES 282 ( ) 1025 ( ) MIP-1α 32 (6-132) 105 (21 577) MIP-1β 14 (0 299) 23 (9-244) Interferon-ɣ 1.0 ( ) 2.7 ( )) Perforin 4.7 ( ) 4.1 ( ) Granzyme A 158 (15 444) 465 ( ) CD ( ) 56.7 ( ) < olkvord J, et al. ARHRV 2005; 21:363

10 Are HIV-Specific CTL deficient in B cell follicles? Skinner, et al, In situ tetramer staining of antigen-specific T cells in tissues. J Immunol 165:613 Skinner, et al, In situ tetramer staining. J Immunol Methods 268:29 Dr. Pamela Skinner

11 CTL ail to Accumulate in ollicles of Untreated HIV+ Lymph Node HLA-A*0201 gag CD20 Connick E.Skinner P. J Immunol 2007;178:6975

12 SIV-Infected Rhesus Macaque Model 1. Does the SIV-infected macaque model recapitulate the distribution of virus and CTL in humans? 2. Does the same pattern occur in all secondary lymphoid tissues?

13 SIV RNA+ Cells Are More requent in vs E in Chronic Infection Without SAIDS p < p < p < Inguinal A xillary S IV R N A + cells/m m S pleen LN LN Mes LN Ileum Cecum Colon 0.01 :E ratio GM 95% CI E , 10.7 E E , 4.0 E E E , 43.4 E Connick E Skinner P. J Immunol 2014; 193:5613.

14 SIV RNA+ Cells Remain Concentrated in after Adjusting for requencies of Target Memory Cells p < SIV RNA+/CD4+CD95+ (X10000) :E ratio GM 95% CI Spleen E Lymph Node E , 12.4 Colon E Connick E Skinner P. J Immunol 2014; 193:5613.

15 SIV-Specific Tetramer Staining Cells Are Concentrated in Extrafollicular Zones p = Red = Mamu B*08/Vif RL8 tetramer Green = CD20 Blue = CD3 Tetram er + c e lls /m m P< E Connick E Skinner P. J Immunol 2014; 193:5613.

16 Effector to Target Cell Ratios are More than 10-old Higher in E vs R atio C TL cells:siv R N A + cells p = E Connick E Skinner P. J Immunol 2014; 193:5613.

17 requencies of CTL are Inversely Related to SIV RNA+ cells in E and SIV R N A + cells/m m p<0.001 LN Extrafollicular L N ollicu lar Spleen Extrafollicular S pleen ollicular C TL cells/m m 2 Connick E Skinner P. J Immunol 2014; 193:5613.

18 Is Virus Replication Concentrated in ollicles in the Absence of a Robust CTL Response? Acute SIV infection when CTL are evolving SAIDS when CTL are losing the ability to control virus CD8 Depletion CD8 cells transiently eliminated Hypothesis: Virus replication is not concentrated in in the absence of a robust CTL response.

19 requencies of SIV RNA+ Cells in ollicles () and Extrafollicular Zones (E) Vary by Disease Stage 14 Day Acute p = 0.99 Chronic p = SA ID S p = SIV R N A + cells/m m E E E :E GM % CI 0.66, , , 3.4 Connick E Skinner P. J Immunol 2014; 193:5613.

20 SIV RNA Increases Primarily in the Extrafollicular Zone after CD8 Depletion SIV RNA copies/m l ( ) Pre Depletion LN CD8 depleting antibodies Post Depletion LN CM9 Tetramer+ T cells/ml blood (-----) S IV R N A + cells/m m Pre ollicle Post E xtrafollicular Zone Pre Post Days post-infection Li S et al. J Virol (in press).

21 Why do CTL fail to accumulate in large numbers in where virus is Homing Phenotype highly concentrated? ew SIV-Specific CTL Exhibit a ollicular 70 %SIV-specific CTL CXCR5+ CXCR5+ CCR7+ CCR7+ CCR7- CXCR5- CXCR5- CCR7- Connick E Skinner P. J Immunol 2014; 193:5613

22 ollicles Are HIV Reservoirs in ART- Treated Individuals (Pallikkuth S, et al. J Virol 2015; 90:2718; Banga R, et al. Nature Med 2016;22:754) RNAscope in Lymph Node of ART-Treated Person (Connick E, unpublished data) HIV RNA in situ+ (red); CD20 (white), DC (green)

23 SIV Targeting CTL to B Cell ollicles To Induce a unctional Cure Isolate CTL and transduce CXCR5 Expand CXCR5+ CTL and CTL alone Discontinue ART and assess localization of CTL and virus vis a vis untransduced CTL Infuse into ARTtreated macaque

24 Acknowledgments Study Participants University of Colorado Joy olkvord Samantha MaWhinney Martin McCarter Mario Santiago Brodie Miles Shannon Miller Amie Meditz Alden Harken Karen Whalen Katie Lind Tessa Arends Wisconsin National Primate Research Center Eva Rakasz Nancy Wilson David Watkins University of Kansas Edward Stephens NYU Dental College David Levy University of MN Pamela Skinner Hyeon Kim Reese Wagstaff Hadia Mohamed Nathan Kemp Shengbin Li unding Agencies/Reagent Resources NIH Tetramer Core acility Nonhuman Primate Reagent Resource

The Role of B Cell Follicles in HIV Replication and Persistence

The Role of B Cell Follicles in HIV Replication and Persistence The Role of B Cell ollicles in HIV Replication and Persistence Elizabeth Connick, M.D. Professor of Medicine Chief, Division of Infectious Diseases University of Arizona July 17, 2016 IAS 2016 Towards

More information

Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection

Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection Received 1 Apr 21 Accepted 1 Sep 21 Published 2 Oct 21 DOI: 1.138/ncomms968 OPEN ollicular regulatory T cells impair follicular T helper cells in HIV and SIV infection Brodie Miles 1, Shannon M. Miller

More information

IMMUNOLOGICAL MEMORY. CD4 T Follicular Helper Cells. Memory CD8 T Cell Differentiation

IMMUNOLOGICAL MEMORY. CD4 T Follicular Helper Cells. Memory CD8 T Cell Differentiation IMMUNOLOGICAL MEMORY CD4 T Follicular Helper Cells Memory CD8 T Cell Differentiation CD4 T Cell Differentiation Bcl-6 T-bet GATA-3 ROR t Foxp3 CD4 T follicular helper (Tfh) cells FUNCTION Provide essential

More information

Supporting Information

Supporting Information Supporting Information Sui et al..7/pnas.997 Pre-CLP CM9 LA9 SL Tat# Pol Vif % Tetramer + CD + CD + Vac+IL- +IL- Vac Fig. S. Frequencies of six different CD + CD + Mamu-A*-tetramer + cells were measured

More information

Alternate Antibody-Based Therapeutic Strategies To Purge the HIV Cell Reservoir

Alternate Antibody-Based Therapeutic Strategies To Purge the HIV Cell Reservoir Alternate Antibody-Based Therapeutic Strategies To Purge the HIV Cell Reservoir Giuseppe Pantaleo, M.D. Professor of Medicine Head, Division of Immunology and Allergy Executive Director, Swiss Vaccine

More information

Viral Reservoirs and anti-latency interventions in nonhuman primate models of SIV/SHIV infection

Viral Reservoirs and anti-latency interventions in nonhuman primate models of SIV/SHIV infection Viral Reservoirs and anti-latency interventions in nonhuman primate models of SIV/SHIV infection Koen Van Rompay California National Primate Research Center University of California Davis Outline Introduction

More information

HLA-DR CD38 CD4 T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-Tropic HIV-1 RNA In Vivo

HLA-DR CD38 CD4 T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-Tropic HIV-1 RNA In Vivo JOURNAL OF VIROLOGY, Oct. 2011, p. 10189 10200 Vol. 85, No. 19 0022-538X/11/$12.00 doi:10.1128/jvi.02529-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. HLA-DR CD38 CD4 T Lymphocytes

More information

Correction. E3366 PNAS April 18, 2017 vol. 114 no

Correction. E3366 PNAS April 18, 2017 vol. 114 no orrection IMMUNOLOGY ND INFLMMTION orrection for Dynamics of SIV-specific XR5+ D8 T cells during chronic SIV infection, by Geetha H. Mylvaganam, Daniel Rios, Hadia M. bdelaal, Smita Iyer, Gregory Tharp,

More information

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS 1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family

More information

Inves)gación básica y curación del VIH- 1

Inves)gación básica y curación del VIH- 1 Inves)gación básica y curación del VIH- 1 Javier Mar)nez- Picado (jmpicado@irsicaixa.es) 23 rd Conference on Retroviruses and Opportunis5c Infec5ons February 22-25, 2016 Boston, Massachuse8s UNIVERSITAT

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION ` SUPPLEMENTAL FIGURES doi:10.1038/nature10003 Supplemental Figure 1: RhCMV/SIV vectors establish and indefinitely maintain high frequency SIV-specific T cell responses in diverse tissues: The figure shows

More information

How HIV Causes Disease Prof. Bruce D. Walker

How HIV Causes Disease Prof. Bruce D. Walker How HIV Causes Disease Howard Hughes Medical Institute Massachusetts General Hospital Harvard Medical School 1 The global AIDS crisis 60 million infections 20 million deaths 2 3 The screen versions of

More information

Gp96-Ig-SIV VACCINES INDUCE PREDOMINANT IMMUNE RESPONSES AT MUCOSAL SITES

Gp96-Ig-SIV VACCINES INDUCE PREDOMINANT IMMUNE RESPONSES AT MUCOSAL SITES Gp96-Ig-SIV VACCINES INDUCE PREDOMINANT IMMUNE RESPONSES AT MUCOSAL SITES Natasa Strbo M.D. Ph.D. Paris, AIDS Vaccine 29 October 19 22 Why is cell secreted gp96 Ig vaccine approach innovative and unconventional?

More information

Alexander O. Pasternak, Mirte Scherpenisse, Ben Berkhout

Alexander O. Pasternak, Mirte Scherpenisse, Ben Berkhout Cell-associated HIV-1 unspliced to multiply spliced RNA ratio at 12 weeks ART correlates with markers of immune activation and apoptosis and predicts the CD4 + T-cell count at 96 weeks ART Alexander O.

More information

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s Putting it Together Stephen Canfield smc12@columbia.edu Secondary Lymphoid System Tonsil Anterior Cervical LN s Axillary LN s Mediastinal/Retroperitoneal LN s Thoracic Duct Appendix Spleen Inguinal LN

More information

5/11/2017. HIV Cure Research Questions and a Few Answers

5/11/2017. HIV Cure Research Questions and a Few Answers HIV Cure Research Questions and a Few Answers Steven G. Deeks, MD Professor of Medicine University of California San Francisco San Francisco, California FORMATTED: 04/13/17 Financial Relationships With

More information

Nature Immunology: doi: /ni Supplementary Figure 1. Id2 and Id3 define polyclonal T H 1 and T FH cell subsets.

Nature Immunology: doi: /ni Supplementary Figure 1. Id2 and Id3 define polyclonal T H 1 and T FH cell subsets. Supplementary Figure 1 Id2 and Id3 define polyclonal T H 1 and T FH cell subsets. Id2 YFP/+ (a) or Id3 GFP/+ (b) mice were analyzed 7 days after LCMV infection. T H 1 (SLAM + CXCR5 or CXCR5 PD-1 ), T FH

More information

Nature Medicine: doi: /nm.4411

Nature Medicine: doi: /nm.4411 Supplementary Figure 1. Plasma viral load decay characteristics in each of 4 monkey cohorts studied after prolonged ART. A. Decay in 5 SIV infected animals treated ART for 20-22 weeks. B, C. Decay in additional

More information

Clinical Education Initiative HIV CONTROLLERS: IMPLICATIONS FOR HIV CURE/REMISSION. Bruce Walker, MD

Clinical Education Initiative HIV CONTROLLERS: IMPLICATIONS FOR HIV CURE/REMISSION. Bruce Walker, MD Clinical Education Initiative Support@ceitraining.org HIV CONTROLLERS: IMPLICATIONS FOR HIV CURE/REMISSION Bruce Walker, MD 6/23/2017 HIV Controllers: Implications for HIV Cure/Remission [video transcript]

More information

cure research HIV & AIDS

cure research HIV & AIDS Glossary of terms HIV & AIDS cure research Antiretroviral Therapy (ART) ART involves the use of several (usually a cocktail of three or more) antiretroviral drugs to halt HIV replication. ART drugs may

More information

Institute t of Experimental Immunology University of Bonn, Germany

Institute t of Experimental Immunology University of Bonn, Germany How T cells recognize antigen Christian Kurts Institute t of Experimental Immunology University of Bonn, Germany When do T cells recognize antigen? Antigen uptake Activation phase 1st recognition Effector

More information

Preclinical Animal Models for HIV Cure Research in Children: Scientific Knowledge Gaps

Preclinical Animal Models for HIV Cure Research in Children: Scientific Knowledge Gaps Preclinical Animal Models for HIV Cure Research in Children: Scientific Knowledge Gaps NIAID Workshop, May 22-23, 2018 Nancy L. Haigwood, Oregon Health & Science University Mississippi baby case brought

More information

Treatment with IL-7 Prevents the Decline of Circulating CD4 + T Cells during the Acute Phase of SIV Infection in Rhesus Macaques

Treatment with IL-7 Prevents the Decline of Circulating CD4 + T Cells during the Acute Phase of SIV Infection in Rhesus Macaques SUPPORTING INFORMATION FOR: Treatment with IL-7 Prevents the Decline of Circulating CD4 + T Cells during the Acute Phase of SIV Infection in Rhesus Macaques Lia Vassena, 1,2 Huiyi Miao, 1 Raffaello Cimbro,

More information

Superior T memory stem cell persistence supports long-lived T cell memory

Superior T memory stem cell persistence supports long-lived T cell memory Brief report Superior T memory stem cell persistence supports long-lived T cell memory Enrico Lugli, 1,2 Maria H. Dominguez, 1 Luca Gattinoni, 3,4 Pratip K. Chattopadhyay, 1 Diane L. Bolton, 1 Kaimei Song,

More information

RAISON D ETRE OF THE IMMUNE SYSTEM:

RAISON D ETRE OF THE IMMUNE SYSTEM: RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Acquired Immunity Innate immunity: (Antigen nonspecific) defense

More information

Pharmacokinetic and pharmacodynamic profile of maraviroc in rhesus macaques after a single oral dose

Pharmacokinetic and pharmacodynamic profile of maraviroc in rhesus macaques after a single oral dose HIV Transmission Workshop 011 Pharmacokinetic and pharmacodynamic profile of maraviroc in rhesus macaques after a single oral dose Wutyi Aung, Amy Martin, Mian-er Cong, Jessica Radzio, Elizabeth Sweeney,

More information

Received 19 September 2007/Accepted 21 November 2007

Received 19 September 2007/Accepted 21 November 2007 JOURNAL OF VIROLOGY, Feb. 2008, p. 1723 1738 Vol. 82, No. 4 0022-538X/08/$08.00 0 doi:10.1128/jvi.02084-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Patterns of CD8 Immunodominance

More information

Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D.

Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D. Regulation of anti-tumor immunity through migration of immune cell subsets within the tumor microenvironment Thomas F. Gajewski, M.D., Ph.D. Professor, Departments of Pathology and Medicine Program Leader,

More information

Supplemental materials

Supplemental materials Supplemental materials 1 Supplemental Fig. 1 Immunogram This immunogram summarizes patient clinical data and immune parameters at corresponding time points for Patient IMF-32. The top panel illustrates

More information

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D. Life Cycle Diagnosis and Pathogenesis Scott M. Hammer, M.D. -1 Virion Entry Life Cycle of Entry -1 virion -1 Virus virion envelope Cell membrane receptor RELEASE OF PROGENY VIRUS REVERSE Co- TRANSCRIPTION

More information

RAISON D ETRE OF THE IMMUNE SYSTEM:

RAISON D ETRE OF THE IMMUNE SYSTEM: RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Adaptive Immunity Innate immunity: (Antigen - nonspecific) defense

More information

Influence of Breastfeeding Practices on HIV-1 Susceptible T Cells in HIV-1 Exposed Ugandan Infants. On behalf of the MAMU Team Elizabeth J.

Influence of Breastfeeding Practices on HIV-1 Susceptible T Cells in HIV-1 Exposed Ugandan Infants. On behalf of the MAMU Team Elizabeth J. Influence of Breastfeeding Practices on HIV-1 Susceptible T Cells in HIV-1 Exposed Ugandan Infants. On behalf of the MAMU Team Elizabeth J. McFarland, MD Professor of Pediatrics University of Colorado

More information

Combination antiretroviral therapy (ART) has. Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure

Combination antiretroviral therapy (ART) has. Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 33, Number S1, 2017 ª Mary Ann Liebert, Inc. DOI: 10.1089/aid.2017.0153 Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure Shahzada

More information

Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells

Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells Sharon A. Riddler, MD, MPH University of Pittsburgh May 2008 Slide 1 HIV and DC Vaccines During

More information

The immune response against cancer

The immune response against cancer The immune response against cancer Maries van den Broek Institute of Experimental Immunology vandenbroek@immunology.uzh.ch The immune system Main cells of the immune system Dendritic cell Monocyte Macrophage

More information

Memory loss: T cell subsets associated with mortality in HIV+ and HIV veterans

Memory loss: T cell subsets associated with mortality in HIV+ and HIV veterans Memory loss: T cell subsets associated with mortality in HIV+ and HIV veterans Wyatt J. McDonnell 1, Meredith S. Duncan 1, John R. Koethe 1, Margaret Doyle 2, Simon Mallal 1, Amy Justice 3, Matthew S.

More information

Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options

Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options Velu et al. Retrovirology (2015) 12:14 DOI 10.1186/s12977-015-0144-x REVIEW Open Access Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options Vijayakumar Velu 1,2*, Ravi

More information

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007 HIV Immunopathogenesis Modeling the Immune System May 2, 2007 Question 1 : Explain how HIV infects the host Zafer Iscan Yuanjian Wang Zufferey Abhishek Garg How does HIV infect the host? HIV infection

More information

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier Micro 204 Cytotoxic T Lymphocytes (CTL) Lewis Lanier Lewis.Lanier@ucsf.edu Lymphocyte-mediated Cytotoxicity CD8 + αβ-tcr + T cells CD4 + αβ-tcr + T cells γδ-tcr + T cells Natural Killer cells CD8 + αβ-tcr

More information

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED Viv Peut Kent Laboratory, University of Melbourne, Australia WHY ENVELOPE? Env subject to both humoral and cellular immune responses Perhaps

More information

David Verhoeven, Sumathi Sankaran, Melanie Silvey, and Satya Dandekar*

David Verhoeven, Sumathi Sankaran, Melanie Silvey, and Satya Dandekar* JOURNAL OF VIROLOGY, Apr. 2008, p. 4016 4027 Vol. 82, No. 8 0022-538X/08/$08.00 0 doi:10.1128/jvi.02164-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Antiviral Therapy during

More information

HIV 101: Fundamentals of HIV Infection

HIV 101: Fundamentals of HIV Infection HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able

More information

Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys

Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys Dan H. Barouch, M.D., Ph.D. Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center Ragon Institute of MGH, MIT,

More information

HIV and Cancer Curative Approaches Cross-disciplinary research. Steven Deeks, MD Professor of Medicine University of California, San Francisco

HIV and Cancer Curative Approaches Cross-disciplinary research. Steven Deeks, MD Professor of Medicine University of California, San Francisco HIV and Cancer Curative Approaches Cross-disciplinary research Steven Deeks, MD Professor of Medicine University of California, San Francisco Cancer immunotherapy is reshaping a fatal and progressive disease

More information

Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques

Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques Luca Micci, Emory University Emily S. Ryan, Emory University Rémi Fromentin, Université de Montréal Steven

More information

IMMUNE CONTROL OF HIV

IMMUNE CONTROL OF HIV IMMUNE CONTROL OF HIV Giuseppe Pantaleo, M.D. Professor of Medicine Head, Division of Immunology and Allergy Executive Director, Swiss Vaccine Research Institute Lausanne University Hospital, Lausanne,

More information

IAS 2015 Towards an HIV Cure symposium Vancouver. Distinct HIV Genetic Populations in Effector Memory T Cells after Prolonged Therapy

IAS 2015 Towards an HIV Cure symposium Vancouver. Distinct HIV Genetic Populations in Effector Memory T Cells after Prolonged Therapy IAS 25 Towards an HIV Cure symposium Vancouver Distinct HIV Genetic Populations in Effector Memory T Cells after Prolonged Therapy Questions about long-lived HIV reservoirs Effective ART Memory CD4+ T

More information

NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies

NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies Saul Kivimäe Senior Scientist, Research Biology Nektar Therapeutics NK Cell-Based Cancer Immunotherapy, September 26-27,

More information

Supplementary Information:

Supplementary Information: Supplementary Information: Follicular regulatory T cells with Bcl6 expression suppress germinal center reactions by Yeonseok Chung, Shinya Tanaka, Fuliang Chu, Roza Nurieva, Gustavo J. Martinez, Seema

More information

SUPPLEMENTARY FIGURE 1

SUPPLEMENTARY FIGURE 1 SUPPLEMENTARY FIGURE 1 A LN Cell count (1 ) 1 3 1 CD+ 1 1 CDL lo CD hi 1 CD+FoxP3+ 1 1 1 7 3 3 3 % of cells 9 7 7 % of cells CD+ 3 1 % of cells CDL lo CD hi 1 1 % of CD+ cells CD+FoxP3+ 3 1 % of CD+ T

More information

B220 CD4 CD8. Figure 1. Confocal Image of Sensitized HLN. Representative image of a sensitized HLN

B220 CD4 CD8. Figure 1. Confocal Image of Sensitized HLN. Representative image of a sensitized HLN B220 CD4 CD8 Natarajan et al., unpublished data Figure 1. Confocal Image of Sensitized HLN. Representative image of a sensitized HLN showing B cell follicles and T cell areas. 20 µm thick. Image of magnification

More information

Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell?

Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? Abbas Chapter 2: Sarah Spriet February 8, 2015 Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? a. Dendritic cells b. Macrophages c. Monocytes

More information

Induction and Clearance of Latent HIV Infection:

Induction and Clearance of Latent HIV Infection: 214 Towards an HIV Cure symposium Melbourne Induction and Clearance of Latent HIV Infection: an Ex-Vivo Assessment of Immune Effectors using Cells from ART-treated Patients DM Margolis 1, C Garrido 1,

More information

Exciting results in monkeys lead to a clinical trial in humans

Exciting results in monkeys lead to a clinical trial in humans From TreatmentUpdate 219 Exciting results in monkeys lead to a clinical trial in humans A close relative of HIV called SIV (simian immunodeficiency virus) causes an AIDS-like disease in susceptible monkeys.

More information

Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome

Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome 30 1, 1, 2, 3 1. ( ), 201508; 2., 200040; 3., 200032 : ( AIDS) ( HIV) 20 90,,,,,, AIDS, CD4 + T ( CTL), HIV, : ; ; Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome

More information

Approaching a Cure Daniel R. Kuritzkes, MD

Approaching a Cure Daniel R. Kuritzkes, MD Approaching a Cure Daniel R. Kuritzkes, MD Division of Infectious Diseases Brigham and Women s Hospital Harvard Medical School Disclosures The speaker is a consultant and/or has received speaking honoraria

More information

Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School

Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School CTLs, Natural Killers and NKTs 1 Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School CTL inducing tumor apoptosis 3 Lecture outline CD8 + Cytotoxic T lymphocytes (CTL) Activation/differentiation

More information

Macrophages and Pulmonary Pathogenesis in Young and Aged SIV-Infected Rhesus Macaques

Macrophages and Pulmonary Pathogenesis in Young and Aged SIV-Infected Rhesus Macaques Macrophages and Pulmonary Pathogenesis in Young and Aged SIV-Infected Rhesus Macaques Yanhui CAI (Jenny) Oct. 20 th, 2014 Division of Immunology Tulane National Primate Research Center Covington, LA 1

More information

The human IL-15 superagonist ALT-803 directs SIV-specific CD8 1 T cells into B-cell follicles

The human IL-15 superagonist ALT-803 directs SIV-specific CD8 1 T cells into B-cell follicles REGULAR ARTICLE The human IL- superagonist ALT-8 directs SIV-specific CD8 T cells into B-cell follicles Gabriela M. Webb,,2, Shengbin Li,, Gwantwa Mwakalundwa, Joy M. Folkvord, 4 Justin M. Greene,,2 Jason

More information

Supporting Information

Supporting Information Supporting Information Horwitz et al. 73/pnas.35295 A Copies ml - C 3NC7 7 697 698 7 7 73 76-2 2 Days Gp2 residue G458D G459D T278A 7/36 N28 K D 28 459 A28T ID# 697 ID# 698 ID# 7 ID# 7 ID# 73 ID# 76 ID#

More information

TCR, MHC and coreceptors

TCR, MHC and coreceptors Cooperation In Immune Responses Antigen processing how peptides get into MHC Antigen processing involves the intracellular proteolytic generation of MHC binding proteins Protein antigens may be processed

More information

Expansion of pre-existing, lymph node-localized CD8 + T cells during supervised treatment interruptions in chronic HIV-1 infection

Expansion of pre-existing, lymph node-localized CD8 + T cells during supervised treatment interruptions in chronic HIV-1 infection Expansion of pre-existing, lymph node-localized CD8 + T cells during supervised treatment interruptions in chronic HIV-1 infection Marcus Altfeld, 1 Jan van Lunzen, 2 Nicole Frahm, 1,2 Xu G. Yu, 1 Claus

More information

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections Amy Chung Dr. Ivan Stratov Prof. Stephen Kent ADCC process consists of Target cell QuickTime and a TIFF (Uncompressed) FcγR decompressor

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES 1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.

More information

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008 Immunity to Viruses Patricia Fitzgerald-Bocarsly September 25, 2008 The Immune System Deals with a Huge Range of Pathogens Roitt, 2003 Immune Responses to Viruses Viruses are dependent on the host cell

More information

Conditionally-live attenuated SIV upregulates global T effector memory cell frequency under replication permissive conditions

Conditionally-live attenuated SIV upregulates global T effector memory cell frequency under replication permissive conditions Manoussaka et al. Retrovirology 213, 1:59 RESEARCH Open Access Conditionally-live attenuated SIV upregulates global T effector memory cell frequency under replication permissive conditions Maria S Manoussaka

More information

Loss of CD96 Expression as a New Biomarker for T-cell Senescence in HIV-1 Infection

Loss of CD96 Expression as a New Biomarker for T-cell Senescence in HIV-1 Infection Loss of CD96 Expression as a New Biomarker for T-cell Senescence in HIV-1 Infection Mohamed El-Far, PhD CHUM research center (CRCHUM) University of Montreal, QC Canada 6th International Workshop on HIV

More information

Nature Medicine: doi: /nm.2109

Nature Medicine: doi: /nm.2109 HIV 1 Infects Multipotent Progenitor Cells Causing Cell Death and Establishing Latent Cellular Reservoirs Christoph C. Carter, Adewunmi Onafuwa Nuga, Lucy A. M c Namara, James Riddell IV, Dale Bixby, Michael

More information

Suppression of HIV replication by lymphoid tissue CD8 cells correlates with the clinical state of HIV-infected individuals

Suppression of HIV replication by lymphoid tissue CD8 cells correlates with the clinical state of HIV-infected individuals Proc. Natl. Acad. Sci. USA Vol. 93, pp. 13125 13130, November 1996 Immunology Suppression of HIV replication by lymphoid tissue CD8 cells correlates with the clinical state of HIV-infected individuals

More information

Collagen Deposition Limits Immune Reconstitution in the Gut

Collagen Deposition Limits Immune Reconstitution in the Gut MAJOR ARTICLE Collagen Deposition Limits Immune Reconstitution in the Gut Jacob Estes, 2,a Jason V. Baker, 1 Jason M. Brenchley, 5 Alex Khoruts, 1 Jacob L. Barthold, 1 Anne Bantle, 1 Cavan S. Reilly, 3

More information

Spleen. mlns. E Spleen 4.1. mlns. Spleen. mlns. Mock 17. Mock CD8 HIV-1 CD38 HLA-DR. Ki67. Spleen. Spleen. mlns. Cheng et al. Fig.

Spleen. mlns. E Spleen 4.1. mlns. Spleen. mlns. Mock 17. Mock CD8 HIV-1 CD38 HLA-DR. Ki67. Spleen. Spleen. mlns. Cheng et al. Fig. C D E F Mock 17 Mock 4.1 CD38 57 CD8 23.7 HLA-DR Ki67 G H I Cheng et al. Fig.S1 Supplementary Figure 1. persistent infection leads to human T cell depletion and hyper-immune activation. Humanized mice

More information

HIV Reservoirs in Developing Countries: Implication for HIV CURE Strategies

HIV Reservoirs in Developing Countries: Implication for HIV CURE Strategies HIV Reservoirs in Developing Countries: Implication for HIV CURE Strategies 10 th INTEREST CONFERENCE 2016, 3-6 TH May 2016, Yaoundé, Cameroon Cissy Kityo 1 ; Thomas Schacker 2 ; Francis Ssali 1 ; Jeffrey

More information

General information. Cell mediated immunity. 455 LSA, Tuesday 11 to noon. Anytime after class.

General information. Cell mediated immunity. 455 LSA, Tuesday 11 to noon. Anytime after class. General information Cell mediated immunity 455 LSA, Tuesday 11 to noon Anytime after class T-cell precursors Thymus Naive T-cells (CD8 or CD4) email: lcoscoy@berkeley.edu edu Use MCB150 as subject line

More information

Adoptive cell therapy using genetically modified antigen-presenting cells

Adoptive cell therapy using genetically modified antigen-presenting cells Adoptive cell therapy using genetically modified antigen-presenting cells Naoto Hirano Ontario Cancer Institute Princess Margaret Cancer Centre University of Toronto UofT-USP Oncology Conference November

More information

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre New insights into CD8+ T cell function and regulation Pam Ohashi Princess Margaret Cancer Centre No Disclosures

More information

LN04 - Lymphoma Tissue Microarray

LN04 - Lymphoma Tissue Microarray Reveal Biosciences offers Histochemical Staining, Immunohistochemistry (IHC), In Situ Hybridization (ISH), Whole Slide Imaging, and Quantitative Image Analysis on any TMA LN04 - Lymphoma Tissue Microarray

More information

Innovative diagnostics for HIV, HBV and HCV

Innovative diagnostics for HIV, HBV and HCV Innovative diagnostics for HIV, HBV and HCV Dan Otelea National Institute for Infectious Diseases Bucharest, Romania Disclaimer No conflicts of interest Innovative diagnostics for HIV, HBV and HCV - is

More information

Eradication of HIV infection Not in my lifetime? or Just around the Corner? Michael M. Lederman, MD

Eradication of HIV infection Not in my lifetime? or Just around the Corner? Michael M. Lederman, MD Eradication of HIV infection Not in my lifetime? or Just around the Corner? Michael M. Lederman, MD Conflicts of Interest The pending clinical trials discussed here are funded by grant awards from Gilead

More information

Impact of Vorinostat Treatment of Non- Hodgkin s Lymphoma on HIV-1 Latent Reservoir

Impact of Vorinostat Treatment of Non- Hodgkin s Lymphoma on HIV-1 Latent Reservoir Impact of Vorinostat Treatment of Non- Hodgkin s Lymphoma on HIV-1 Latent Reservoir Adam Capoferri, Juan Carlos Ramos, Daniel Xu, Daniel I.S. Rosenbloom, Janet D. Siliciano, Robert F. Siliciano, Ariela

More information

Tissue-Specific B-Cell Dysfunction and Generalized Memory B-Cell Loss during Acute SIV Infection

Tissue-Specific B-Cell Dysfunction and Generalized Memory B-Cell Loss during Acute SIV Infection Tissue-Specific B-Cell Dysfunction and Generalized Memory B-Cell Loss during Acute SIV Infection Sandrine Peruchon 1,2, Nada Chaoul 1, Chantal Burelout 1, Benoit Delache 1, Patricia Brochard 1, Pascale

More information

Low immune activation despite high levels of pathogenic HIV-1 results in long-term asymptomatic disease

Low immune activation despite high levels of pathogenic HIV-1 results in long-term asymptomatic disease Low immune activation despite high levels of pathogenic HIV-1 results in long-term asymptomatic disease Shailesh K. Choudhary 1 *, Nienke Vrisekoop 2 *, Christine A. Jansen 2, Sigrid A. Otto 2, Hanneke

More information

MHRP. Outline. Is HIV cure possible? HIV persistence. Cure Strategies. Ethical and social considerations. Short video on patients perspectives on cure

MHRP. Outline. Is HIV cure possible? HIV persistence. Cure Strategies. Ethical and social considerations. Short video on patients perspectives on cure Outline Is HIV cure possible? Ø HIV persistence Cure Strategies Ethical and social considerations Short video on patients perspectives on cure A Case of Cure Off ART Treatment Mechanism Lesson The Berlin

More information

Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia

Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia AIDSvaccine conference, 14 th September 2011 IMGT HLA database July 2011 >5000 class

More information

Early treatment of SIV plus macaques with an alpha(4)beta(7) mab alters virus distribution and preserves CD4(+) T cells in later stages of infection

Early treatment of SIV plus macaques with an alpha(4)beta(7) mab alters virus distribution and preserves CD4(+) T cells in later stages of infection Early treatment of SIV plus macaques with an alpha(4)beta(7) mab alters virus distribution and preserves CD4(+) T cells in later stages of infection Philip J. Santangelo, Emory University Claudia Cicala,

More information

Location and Dynamics of the Immunodominant CD8 T Cell Response to SIVΔnef Immunization and SIVmac251 Vaginal Challenge

Location and Dynamics of the Immunodominant CD8 T Cell Response to SIVΔnef Immunization and SIVmac251 Vaginal Challenge Location and Dynamics of the Immunodominant CD8 T Cell Response to SIVΔnef Immunization and SIVmac251 Vaginal Challenge The Harvard community has made this article openly available. Please share how this

More information

Characterization of CD8 + T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling

Characterization of CD8 + T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling RESEARCH ARTICLE Characterization of CD8 + T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling James M. Billingsley 1,2, Premeela A. Rajakumar 1,2, Michelle

More information

CLINICAL. Immune Restoration in the Context of HAART

CLINICAL. Immune Restoration in the Context of HAART CLINICAL Immune Restoration in the Context of HAART Des Martin, MB ChB, MMed, FCPath, DTM&H, DPH University of the Witwatersrand and SA HIV Clinicians Society The advent of highly active antiretroviral

More information

What to Measure, How to Measure It

What to Measure, How to Measure It Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Monitoring Memory T-cells: What to Measure, How to Measure It Pratip K.

More information

7/6/2009. The study of the immune system and of diseases that occur as a result of inappropriate or inadequate actions of the immune system.

7/6/2009. The study of the immune system and of diseases that occur as a result of inappropriate or inadequate actions of the immune system. Diseases of Immunity 2009 CL Davis General Pathology Paul W. Snyder, DVM, PhD Purdue University Acknowledgements Pathologic Basis of Veterinary Disease, 4 th Ed Veterinary Immunology, An Introduction 8

More information

SUPPLEMENTARY INFORMATION. Divergent TLR7/9 signaling and type I interferon production distinguish

SUPPLEMENTARY INFORMATION. Divergent TLR7/9 signaling and type I interferon production distinguish SUPPLEMENTARY INFOATION Divergent TLR7/9 signaling and type I interferon production distinguish pathogenic and non-pathogenic AIDS-virus infections Judith N. Mandl, Ashley P. Barry, Thomas H. Vanderford,

More information

Chapter 2 (pages 22 33): Cells and Tissues of the Immune System. Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group

Chapter 2 (pages 22 33): Cells and Tissues of the Immune System. Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group Allergy and Immunology Review Corner: Cellular and Molecular Immunology, 8th Edition By Abul K. Abbas, MBBS; Andrew H. H. Lichtman, MD, PhD; and Shiv Pillai, MBBS, PhD. Chapter 2 (pages 22 33): Cells and

More information

The role of CMV in the long term outcome for older Australians, renal transplant recipients and HIV patients

The role of CMV in the long term outcome for older Australians, renal transplant recipients and HIV patients The role of in the long term outcome for older Australians, renal transplant recipients and HIV Some well known facts is a herpes virus so it is has a DNA genome It replicates in fibroblasts, monocytes

More information

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve

More information

T-Pharmacytes for the Targeted Eradication of HIV Reservoirs

T-Pharmacytes for the Targeted Eradication of HIV Reservoirs T-Pharmacytes for the Targeted Eradication of HIV Reservoirs Walker Lab Rachel O Connor Alicja Trocha Dan Karel Irvine Lab Stefanie Mueller Humanized Mouse Core Vlad Vrbanac Andy Tager Todd Allen Darrell

More information

Acquired Immunity 2. - Vaccines & Immunological Memory - Wataru Ise. WPI Immunology Frontier Research Center (IFReC) Osaka University.

Acquired Immunity 2. - Vaccines & Immunological Memory - Wataru Ise. WPI Immunology Frontier Research Center (IFReC) Osaka University. Acquired Immunity 2 - Vaccines & Immunological Memory - Wataru Ise WPI Immunology Frontier Research Center (IFReC) Osaka University Outline 1. What is vaccine (vaccination)? 2. What is immunological memory?

More information

Immunodeficiency. (2 of 2)

Immunodeficiency. (2 of 2) Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related

More information

Dendritic Cell Based Immunotherapy for Cancer. Edgar G. Engleman, M.D.

Dendritic Cell Based Immunotherapy for Cancer. Edgar G. Engleman, M.D. Dendritic Cell Based Immunotherapy for Cancer Edgar G. Engleman, M.D. Two main DC subsets Myeloid (mydc) Derived from monocytes Capture/process/present Ag to T cells Activate NK cells and B cells Plasmacytoid

More information

Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4

Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4 Human Immunodeficiency Virus Type-1 Myeloid Derived Suppressor Cells Inhibit Cytomegalovirus Inflammation through Interleukin-27 and B7-H4 Ankita Garg, Rodney Trout and Stephen A. Spector,,* Department

More information

EBV Infection and Immunity. Andrew Hislop Institute for Cancer Studies University of Birmingham

EBV Infection and Immunity. Andrew Hislop Institute for Cancer Studies University of Birmingham EBV Infection and Immunity Andrew Hislop Institute for Cancer Studies University of Birmingham EBV Introduction Large ds DNA virus Spread by saliva contact Lifelong infection Predominantly B-lymphotropic

More information

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic 1 Two attributes make AIDS unique among infectious diseases: it is uniformly fatal, and most of its devastating symptoms are not due to the causative agent Male to Male sex is the highest risk group in

More information